A Multicenter, Retrospective Study Comparing the Real-World Efficacy and Safety of Apremilast Monotherapy (MT) to Combination Therapy (CT) for the Treatment of Plaque Psoriasis (PP)
Latest Information Update: 17 May 2018
At a glance
- Drugs Apremilast (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Therapeutic Use
- 03 May 2018 Results (n=48) evaluating long term, 52 week efficacy and safety published in the Journal of the American Academy of Dermatology
- 16 Oct 2017 New trial record
- 05 Oct 2017 Results published in the Journal of the American Academy of Dermatology